Pharma Mar
(OTC) PHMMF
Pharma Mar Financials at a Glance
Market Cap
$1.58BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
€225.46M
Net Income (TTM)
€80.55M
EPS (TTM)
$5.31
P/E Ratio
17.09
Dividend
$0.00
Beta (Volatility)
-0.03 (Low)
Dividend
$0.00
Beta (Volatility)
-0.03 (Low)
Price
$90.90
Volume
102
Open
$90.90
Price
$90.90
Volume
102
Open
$90.90
Previous Close
$90.90
Daily Range
$90.90 - $90.90
52-Week Range
$77.41 - $110.40
Estimated Earnings Date
Jul 29, 2026
Dividend
$0.00
Beta (Volatility)
-0.03 (Low)
Price
$90.90
Volume
102
Open
$90.90
Previous Close
$90.90
Daily Range
$90.90 - $90.90
52-Week Range
$77.41 - $110.40
Estimated Earnings Date
Jul 29, 2026
PHMMF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pharma Mar
Industry
Biotechnology
Sector
Health CareCEO
José Maria Fernández de Sousa-Faro, PhD, MBA
Website
www.pharmamar.comHeadquarters
Madrid, MA 28770, ES
PHMMF Financials
Key Financial Metrics (TTM)
Gross Margin
92.66%
Operating Margin
26.12%
Net Income Margin
35.70%
Return on Equity
35.74%
Return on Capital
13.37%
Return on Assets
20.89%
Earnings Yield
5.85%
Dividend Yield
0.00%
Payout Ratio
17.33%
Stock Overview
Market Cap
$1.58BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
17.36M
Volume
102
Avg. Volume
180.71
Financials (TTM)
Gross Profit
€208.90M
Operating Income
€58.87M
EBITDA
€69.17M
Operating Cash Flow
€68.02M
Capital Expenditure
-€10.22M
Free Cash Flow
€57.79M
Cash & ST Invst.
€167.85M
Total Debt
€47.54M
Pharma Mar Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
€42.90M
+10.4%
Gross Profit
€39.24M
+10.7%
Gross Margin
91.47%
N/A
Market Cap
$1.58BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$3.16M
N/A
Employees
500
N/A
Net Income
€1.53M
+138.8%
EBITDA
€2.71M
+346.3%
Quarterly Fundamentals
Total Cash
€167.85M
+19.2%
Total Debt
€47.54M
-8.5%
Accounts Receivable
€39.95M
+8.6%
Inventory
€53.12M
+5.1%
Long Term Debt
€34.48M
-14.3%
Short Term Debt
€13.06M
+11.6%
Return on Assets
20.89%
N/A
Return on Invested Capital
19.89%
N/A
Free Cash Flow
€7.24M
+206.6%
Operating Cash Flow
€8.58M
+236.6%